Fellowship ​

Professor Roger Reddel is a medical oncologist and cancer researcher who is internationally recognised for major contributions to understanding cellular immortality – an almost universal characteristic of cancers – and especially the role of telomere lengthening mechanisms. He also has a medical research leadership role as executive director of Children’s Medical Research Institute, and within many medical research networks including Sydney Health Partners. He is Director of CellBank Australia, and co-director of the Australian Cancer Research Foundation International Centre for the Proteome of Human Cancer, which aims to improve the accuracy of treatment decisions for individual cancer patients.

GL BSc(UM) PhD MBBS FRACP, Co-Medical Director of Melanoma Institute Australia, and President-elect for the prestigious international ‘Society for Melanoma Research’, is an international key-opinion leader in melanoma medical oncology and translational research, focusing on drivers of response and resistance to novel drugs. GL has published >130 peer-reviewed papers since 2011 (6xNEngJMed), and has obtained major NHMRC program-grant funding (co-chief investigator). GL has been an invited speaker at >120 international meetings, is Scientific Committee Track-Leader for the prestigious American Society for Clinical Oncology 2015/16, and for the European equivalent (ESMO ’18/ESMO-Asia ’17). She is a member of key boards, steering committees (AJCC staging), and guideline working-groups, is associate-editor and reviewer for high-impact journals (+editorial boards), & reviews grants (NHMRC).

Prof Sherrington is an NHMRC Senior Research Fellow at the George Institute for Global Health and Sydney Medical School, The University of Sydney. She leads the 17-person Ageing and Physical Disability Research Group within the Institute’s Musculoskeletal Division. Her research focuses on the promotion of physical activity and prevention of falls in older people and people with chronic disabling conditions. Her publications have been cited over 12,600 times. She is an international pioneer in the conduct of large-scale pragmatic clinical trials and systematic reviews about exercise and falls prevention. She has been Chief Investigator on NHMRC grants totalling $15.2 million.

Phil Hogg discovered a unique mechanism of control of protein function that operates across all biological systems and lifeforms. This involves a subset of disulphide bonds thought only to act as covalent modifiers of protein structure functioning as molecular switches to allosterically regulate protein function when cleaved. He developed a novel classification scheme for disulphides and uncovered a conformational signature for the allosteric bonds that underpins their facile nature. He has shown that thrombosis as well as immune responses and viral infections are critically regulated by this previously unrecognised chemical modification.

Philip Mitchell is an international authority in the fields of bipolar disorder and depression, with his major achievements spanning the breadth of genetics, phenomenology, treatment and epidemiology of these conditions. He has identified distinguishing clinical characteristics of bipolar depression, demonstrated specific differences in brain functioning of young people at risk to bipolar disorder, and has published the only two Australian national epidemiological reports on bipolar disorder.

As President of the Australasian Society for Bipolar and Depressive Disorders and Vice-President of the International Society for Bipolar Disorders, Mitchell is a leading discipline figure and a most worthy addition to the Fellowship.